Last Price Today's Change   Day's Range   Trading Volume
0.081   0.00 (0.00%)  0.081 - 0.083  2,146,392


Avg Volume (4 weeks):5,298,757
4 Weeks Range:0.055 - 0.102
4 Weeks Price Volatility (%):
52 Weeks Range:0.014 - 0.445
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Biotron Limited is an Australia-based biotechnology company. The Company is engaged in the funding and management of intermediate, and applied biotechnology research and development projects. The Company is focused on the ongoing clinical development of its antiviral platform. The Company's lead antiviral drug, BIT225 is in mid-stage clinical development with approximately eight clinical trials completed. The Company has conducted clinical trails in human immunodeficiency virus-1 (HIV-1), hepatitis C virus (HCV) and HIV-1/HCV co-infected population. The clinical trials showed that BIT225 targets and reduces levels of HIV-1 residing in long-lived monocyte/macrophage reservoirs. BIT225 has clinical antiviral activity against both HIV-1 and HCV. BIT225 is pan-genotypic and is active against all HCV genotypes, including GT3. The Company designs and develops drugs that target a class of virus protein known as viroporins. Its earlier stage programs include Dengue, Influenza and others.

  Be the first to like this.


535  665  650  9299 

Top 10 Active Counters
 IBX 0.051+0.031 
 OVL 0.007+0.002 
 S32 2.98-0.05 
 NTI 0.028+0.006 
 TLS 3.81+0.02 
 PIO 0.016+0.002 
 LRS 0.0010.00 
 ECT 0.004-0.001 
 ESH 0.012-0.001 
 AMP 1.78-0.02 
Partners & Brokers